Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorKaymakcalan, Hande
dc.contributor.authorYalcinkaya, Leyla
dc.contributor.authorNikerel, Emrah
dc.contributor.authorYalcin, Yalim
dc.contributor.authorDong, Weilai
dc.contributor.authorSencicek, Adife Gulhan Ercan
dc.date.accessioned2022-11-04T19:55:40Z
dc.date.available2022-11-04T19:55:40Z
dc.date.issued2022
dc.identifier.issn1309-9469
dc.identifier.urihttps://doi.org/10.5472/marumj.1120570
dc.identifier.urihttp://hdl.handle.net/11446/4594
dc.description.abstractObjective: We aimed to evaluate the demographic and clinical characteristics of children with congenital heart disease (CHD) in a private pediatric cardiovascular genetics clinic in Istanbul from January 2016 to July 2018 and increase the awareness and emphasize the importance of genetic counseling in CHD. Patients and Methods: One hundred and seventeen patients (50 female, 67 male) from 3 days of age to 25 years of age in 17 months period ( January 2016 to July 2018) were retrospectively analyzed. Data included age, sex, echocardiography results, extracardiac features, genetic test results, consanguinity and any family member with heart disease. Pearson's chi-squared test with 1 degree of freedom and 5% significance was used for correlations. Results: Consanguinity rate was 23.9%. Most common diagnosis was Tetralogy of Fallot (TOF) followed by atrial septal defect (ASD) and ventricular septal defect (VSD) equally. 30 patients had genetic testing which revealed a diagnosis in 36.6 % of the patients. 6 patients had DiGeorge, one had Renpenning,onc had Kabuki syndrome. We had one NODAL, one MYH7 and one MYH6 variant. Conclusion: Genetic testing in CHD has a high diagnostic yield. Genetic counseling can help diagnostic, prognostic, and therapeutic and family planning decision making.en_US
dc.description.sponsorshipYale Center for Mendelian Genomics [UM1HG006504]; National Human Genome Research Institute; National Heart, Lung, and Blood Instituteen_US
dc.description.sponsorshipThis work was supported by The Yale Center for Mendelian Genomics (UM1HG006504) which is funded by the National Human Genome Research Institute and National Heart, Lung, and Blood Institute.en_US
dc.language.isoengen_US
dc.publisherMarmara Univ, Fac Medicineen_US
dc.relation.ispartofMarmara Medical Journalen_US
dc.identifier.doi10.5472/marumj.1120570en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCongenital heart diseaseen_US
dc.subjectGeneticsen_US
dc.subjectGenetic counselingen_US
dc.subjectDe-Novo Mutationsen_US
dc.subject22q11.2 Deletionen_US
dc.subjectVariantsen_US
dc.titleClinical, demographic and genetic features of patients with congenital heart disease : A single center experienceen_US
dc.typearticleen_US
dc.identifier.issue2en_US
dc.identifier.volume35en_US
dc.identifier.startpage159en_US
dc.identifier.endpage163en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-temp[Kaymakcalan, Hande] Demiroglu Bilim Univ, Sch Med, Dept Med Genet, Istanbul, Turkey; [Yalcinkaya, Leyla] Bilkent Univ, Fac Sci, Dept Mol Biol & Genet, Ankara, Turkey; [Nikerel, Emrah] Yeditepe Univ, Fac Engn, Genet & Bioengn Dept, Istanbul, Turkey; [Yalcin, Yalim] Demiroglu Bilim Univ, Sch Med, Dept Pediat, Pediat Cardiol Unit, Istanbul, Turkey; [Dong, Weilai; Sencicek, Adife Gulhan Ercan] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Dong, Weilai] Rockefeller Univ, Lab Human Genet & Genom, 1230 York Ave, New York, NY 10021 USA; [Sencicek, Adife Gulhan Ercan] Masonic Med Res Inst, Biomed Res & Translat Med, Utica, NY USAen_US
dc.identifier.scopus2-s2.0-85132074147en_US
dc.identifier.wosWOS:000806472400007en_US
dc.authorscopusid15032986100
dc.authorscopusid57226030133
dc.authorscopusid55212161400
dc.authorscopusid57207543931
dc.authorscopusid57198896351
dc.authorscopusid9242823300


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster